Health Care Revance Therapeutics grows Nashville office, therapeutic pipeline Hannah Herner Updated Sep 22, 2023 Area biotech company gaining speed one year after Daxxify FDA approval
Health Care Pregnancy loss patients caught in mifepristone crossfire Hannah Herner Updated Aug 28, 2023 VUMC research shows FDA-backed drug underutilizedÂ
Area Stocks Harrow buys four FDA-approved brands for $14M Kara Hartnett Updated Jan 21, 2022 Commercial rights will help company expand surgical, acute offerings
Area Stocks Cumberland Pharma shares double on FDA approval Staff Reports Updated Jan 21, 2022 Company's ibuprofen injection granted expanded use
Development Cumberland Pharmaceuticals moving HQ to Broadwest Staff Reports Updated Nov 24, 2021 Biopharma firm joins LP Building Solutions, Shore Capital, Robert W. Baird at development
Health Care Featured TennCare waiver faces mostly opposition in federal comment period Kara Hartnett Updated Sep 17, 2021 Dissenters hope for the Biden Administration to repeal the safety-net insurance overhaul
Home BioMimetic FDA submissions complete Erin Lawley Feb 18, 2010 BioMimetic Therapeutics' Augment Bone Graft product is another step closer to U.S. commercialization. The company (Ticker: BMTI) said Wednesda…
